Ocular Therapeutix™ to Host 2019 Research & Development Day

BEDFORD, Mass.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank"gt;#OCUTXlt;/agt;--Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will host a Research & Development Day to provide updates on the commercial plans for DEXTENZA and a deeper dive into the hydrogel platform and the Company’s pipeline. The event will include presentations by members of Ocular Therapeutix’s seni

Full Story →